Correction: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum: Evaluating the Comparative Efficacy of Sodium-Glucose Cotransporter-2 Inhibitors in New-Onset Gastric Cancer and Related Gastric Conditions Among Type 2 Diabetes Patients: A Population-Based Cohort Analysis

  • By

  • Oscar Hou In Chou

  • Vinod Kumar Chauhan

  • Cheuk To Skylar Chung

  • Lei Lu

  • Teddy Tai Loy Lee

  • Zita Man Wai Ng

  • Karin Kai Wing Wang

  • Sharen Lee

  • Haipeng Liu

  • Ronald Ting Kai Pang

  • Apichat Kaewdech

  • Bernard Man Yung Cheung

  • Gary Tse

  • Jiandong Zhou

  • August 31, 2026

Share

Original Source(s)

Correction: Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohort study

  • by Oscar Hou In Chou, Vinod Kumar Chauhan, Cheuk To Skylar Chung, Lei Lu, Teddy Tai Loy Lee, Zita Man Wai Ng, Karin Kai Wing Wang, Sharen Lee, Haipeng Liu, Ronald Ting Kai Pang, Apichat Kaewdech, Bernard Man Yung Cheung, Gary Tse, Jiandong Zhou

  • August 31, 2026

Related Content

Cancer Communication in an Era of Fragmented Trust

This Week’s CGT News: Bristol Myers Ends Cellares Manufacturing Agreement

A first-in-human study reduces stem-cell collection and manufacturing times, Bristol Myers ends its Breyanzi agreement with Cellares, and two approaches strengthen CAR T-cell activity against solid tumors

  • August 31, 2026

  • 5 min
Correction: Transplantation outcomes in Philadelphia-positive acute lymphoblastic leukemia with additional cytogenetic abnormalities: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation